Literature DB >> 9833996

Enhanced encapsulation of amphotericin B into liposomes by complex formation with polyethylene glycol derivatives.

K Moribe1, E Tanaka, K Maruyama, M Iwatsuru.   

Abstract

PURPOSE: A highly efficient method was developed for the encapsulation of amphotericin B (AmB) in liposomes, and the mechanism involved was characterized.
METHODS: AmB was encapsulated in dipalmitoylphosphatidylcholine/ cholesterol (DPPC/CH, 2:1) liposomes after complex formation with distearoyl-N-(monomethoxy poly(ethylene glycol)succinyl) phosphatidylethanolamine (DSPE-PEG). Hydration of lipids was done with 9% sucrose solution.
RESULTS: The encapsulated amount of AmB was 111 microg/mg lipid, which was much higher than that obtained by the same method without DSPE-PEG (14 microg/mg lipid). The amount encapsulated increased with amount of DSPE-PEG used and with PEG molecular weight. Encapsulation efficacy was also influenced by the type of PEG derivatives used and by the modification of AmB, suggesting the involvement of complex formation between AmB and DSPE-PEG. Absorption and 31P-NMR spectral analyses indicated that interactions between the amino and phosphate groups and between the polyene and PEG moieties in AmB and DSPE-PEG, respectively, play an important role in the complex formation.
CONCLUSIONS: Complex formation of AmB with DSPE-PEG allows the highly efficient encapsulation of the drug in liposomes. This simple technique should be applicable to other hydrophobic drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9833996     DOI: 10.1023/a:1011912829747

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Polyene macrolide antibiotic amphotericin B. Crystal structure of the N-iodoacetyl derivative.

Authors:  P Ganis; G Avitabile; W Mechlinski; C P Schaffner
Journal:  J Am Chem Soc       Date:  1971-09-08       Impact factor: 15.419

2.  Ion coordination in the amphotericin B channel.

Authors:  V Khutorsky
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

3.  One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium.

Authors:  J Bolard; P Legrand; F Heitz; B Cybulska
Journal:  Biochemistry       Date:  1991-06-11       Impact factor: 3.162

4.  Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice.

Authors:  T Otsubo; K Maruyama; S Maesaki; Y Miyazaki; E Tanaka; T Takizawa; K Moribe; K Tomono; T Tashiro; S Kohno
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol).

Authors:  A K Kenworthy; S A Simon; T J McIntosh
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

6.  Theoretical study of the complexation of amphotericin B with sterols.

Authors:  J Langlet; J Bergès; J Caillet; J P Demaret
Journal:  Biochim Biophys Acta       Date:  1994-04-20

7.  Lipid-amphotericin B complex structure in solution: a possible first step in the aggregation process in cell membranes.

Authors:  A R Balakrishnan; K R Easwaran
Journal:  Biochemistry       Date:  1993-04-20       Impact factor: 3.162

Review 8.  Amphotericin B and its delivery by liposomal and lipid formulations.

Authors:  C Gates; R J Pinney
Journal:  J Clin Pharm Ther       Date:  1993-06       Impact factor: 2.512

9.  Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).

Authors:  K Maruyama; T Yuda; A Okamoto; S Kojima; A Suginaka; M Iwatsuru
Journal:  Biochim Biophys Acta       Date:  1992-09-22

10.  Effect of the modifications of ionizable groups of amphotericin B on its ability to form complexes with sterols in hydroalcoholic media.

Authors:  J Mazerski; J Bolard; E Borowski
Journal:  Biochim Biophys Acta       Date:  1995-05-24
View more
  2 in total

1.  A Nanocarrier Skin-Targeted Drug Delivery System using an Ascorbic Acid Derivative.

Authors:  Yutaka Inoue; Mitsue Hibino; Isamu Murata; Ikuo Kanamoto
Journal:  Pharm Res       Date:  2017-12-28       Impact factor: 4.200

2.  Drug nanoparticle formulation using ascorbic Acid derivatives.

Authors:  Kunikazu Moribe; Waree Limwikrant; Kenjirou Higashi; Keiji Yamamoto
Journal:  J Drug Deliv       Date:  2011-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.